Net Income (Loss) Attributable to Parent in USD of Trevi Therapeutics, Inc. from Q1 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Trevi Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2018 to Q3 2025.
  • Trevi Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$11.8M, a 10.9% increase year-over-year.
  • Trevi Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$45.9M, a 3.48% decline year-over-year.
  • Trevi Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$47.9M, a 64.8% decline from 2023.
  • Trevi Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$29.1M, a 0.3% increase from 2022.
  • Trevi Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$29.2M, a 14.1% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Trevi Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$45.9M -$11.8M +$1.44M +10.9% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 -$47.3M -$12.3M +$51K +0.41% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 -$47.3M -$10.3M +$562K +5.16% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 -$47.9M -$11.4M -$3.59M -46% 01 Oct 2024 31 Dec 2024 10-K 18 Mar 2025
Q3 2024 -$44.3M -$13.2M -$5.54M -72% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 -$38.8M -$12.4M -$5.21M -72.9% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 -$33.6M -$10.9M -$4.5M -70.3% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 -$29.1M -$7.82M -$2.32M -42.1% 01 Oct 2023 31 Dec 2023 10-K 18 Mar 2025
Q3 2023 -$26.7M -$7.7M +$568K +6.87% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024
Q2 2023 -$27.3M -$7.15M +$907K +11.3% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$28.2M -$6.4M +$928K +12.7% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024
Q4 2022 -$29.2M -$5.51M +$3.02M +35.4% 01 Oct 2022 31 Dec 2022 10-K 20 Mar 2024
Q3 2022 -$32.2M -$8.27M -$1.01M -13.9% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$31.2M -$8.05M +$1.74M +17.8% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 -$32.9M -$7.33M +$1.04M +12.4% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 -$33.9M -$8.52M +$1M +10.5% 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023
Q3 2021 -$34.9M -$7.26M +$123K +1.67% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$35.1M -$9.79M -$2.41M -32.6% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 -$32.7M -$8.37M +$102K +1.2% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 -$32.8M -$9.52M -$2.99M -45.7% 01 Oct 2020 31 Dec 2020 10-K 17 Mar 2022
Q3 2020 -$29.8M -$7.38M -$13K -0.18% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$29.8M -$7.38M -$38K -0.52% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 -$29.7M -$8.47M -$3.67M -76.4% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 -$26.1M -$6.54M -$555K -9.28% 01 Oct 2019 31 Dec 2019 10-K 25 Mar 2021
Q3 2019 -$25.5M -$7.37M -$1.71M -30.3% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 -$23.8M -$7.35M -$2.49M -51.2% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020
Q1 2019 -$21.3M -$4.8M -$751K -18.5% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020
Q4 2018 -$20.5M -$5.98M 01 Oct 2018 31 Dec 2018 10-K 16 Mar 2020
Q3 2018 -$5.65M 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 -$4.86M 01 Apr 2018 30 Jun 2018 10-Q 12 Aug 2019
Q1 2018 -$4.05M 01 Jan 2018 31 Mar 2018 10-Q 14 Jun 2019

Trevi Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$47.9M -$18.8M -64.8% 01 Jan 2024 31 Dec 2024 10-K 18 Mar 2025
2023 -$29.1M +$87K +0.3% 01 Jan 2023 31 Dec 2023 10-K 18 Mar 2025
2022 -$29.2M +$4.79M +14.1% 01 Jan 2022 31 Dec 2022 10-K 20 Mar 2024
2021 -$33.9M -$1.18M -3.61% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023
2020 -$32.8M -$6.71M -25.8% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022
2019 -$26.1M -$5.51M -26.8% 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2021
2018 -$20.5M 01 Jan 2018 31 Dec 2018 10-K 16 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.